Caitlyn Fitzpatrick

Not only has "the world's most sensitive test to detect and diagnose infectious disease" been developed, but it has the potential to become a doctor's office staple.

Fresh off the heels of research revealing that this year's flu vaccine was only effective in one out of 4 people, investigators are now taking steps to develop a universal vaccine.

While cognitive behavioral therapy has been used to treat patients with insomnia, evidence backing the treatment for those who also have other psychiatric and medical conditions has not been available until now.

Two major changes in opioid dispensing that were placed into action in 2010 have made significant impacts on the prescription drug abuse epidemic.

Osteoarthritis (OA) is a crippling condition with the majority of cases taking place in the knee – but what's the best form of treatment?

Weighing the pros and cons of prescription opioid use for chronic pain is an ongoing battle, and new research may have just added to the list of disadvantages.

Antimicrobial resistance (AMR) may not be a new concept, but coming up with novel strategies to stop its progression is only becoming increasingly critical.

With 259 million painkiller prescriptions written in 2012 alone, according to the Centers for Disease Control and Prevention (CDC), one of the most common side effects experienced by patients being treated for chronic pain is opioid-induced constipation (OIC).

A new study proves that too much of a good thing can cause serious harm – even if it is a vitamin.

Patients who suffer from migraine headaches may find relief in the severity, frequency, and duration with the help of 2 procedures.

Researchers from Hiroshima University have created a system to detect a drug-resistant viral strain mutation in hepatitis C (HCV) cases.

For the first time, researchers have evidence identifying the key cells behind the pain imbalance between genders.

It has been estimated that only one out of 4 people who received the 2014-2015 flu vaccine were protected from the illness.

Although a promising Ebola vaccine trial was recently closed, a different type of drug may prove to be an effective treatment for the deadly disease.

Antibiotic resistance is an ongoing battle and a new method of testing for deadly infections may help prevent physicians from prescribing unnecessary medications.

It should be common knowledge that prescription opioids have addictive properties, yet alarming survey results reveal that many healthcare providers do not understand the extent to which this is the case.

In addition to killing emotions and proving to be ineffective for back pain and osteoarthritis, the most common drug ingredient in the US can also cause severe bodily harm.

A proportion of people who are exposed to the human immunodeficiency virus (HIV) never become infected – but how? The long-awaited answer to this question has finally been determined.

A new opioid will soon be on the market now that final approval from the United States Food & Drug Administration (FDA) has been confirmed.

While there are not currently any vaccines to combat the deadly Ebola virus, one of the prospective drugs just delivered some unfavorable news.

With many Americans blaming overprescribing for the painkiller abuse epidemic, novel treatments excluding medication – such as the oxygen chamber – are few and far between. However, a new analysis may have uncovered one for patients with chronic lower back pain.

Potentially addictive opioids may be avoidable thanks to a new treatment pathway for chronic pain and other painful conditions by focusing on genetics.

A gout medication did not show significant statistical benefit in lowering flares associated with the condition.

A single-shot vaccine against the human immunodeficiency virus (HIV) will never become a reality, according to researchers from The Rockefeller University, but stimulating the immune system may lead to improved preventive treatments.

Multiple studies have demonstrated the efficacy of a new class of drugs for preventing the intense pain and crippling effects of migraines.

The number-one cause of death in children under the age of 5 worldwide has also been shown to harm DNA.

A medication commonly prescribed to relieve the painful symptoms of multiple types of arthritis has been found to be ineffective in treating pain associated with one particular form of the disease.

Since vitamin D plays an important role in immune system responses, it may also be crucial in curtailing the deadly epidemic of the human immunodeficiency virus (HIV).

A promising new tool has been developed to help the ongoing fight against antibiotic resistance by analyzing the bacteria population, according to a team from Icahn School of Medicine at Mount Sinai in New York City.

Patients are often asked their level of pain on a scale of 0 to 10, but a new study suggests this may not be the most efficient way to distribute the appropriate dosage of drugs.